Botox (onabotulinumtoxinA) injections for excessive sweating

At a glance

Mechanism of action

Botox type A blocks acetylcholine release at the presynaptic neuromuscular junction, including the cholinergic sympathetic nerves that drive eccrine sweat glands. The effect is local to the injection site and persists until nerve terminals regenerate.

FDA approval and off-label use

OnabotulinumtoxinA is FDA-approved for severe primary excessive underarm sweating in adults inadequately managed by topical agents. The approval rests on Phase 3 trial data showing meaningful gravimetric and patient-reported reductions at multiple post-injection time points. Use for hand, foot, and excessive face and scalp sweating is off-label but supported by extensive case-series and open-label studies; specialist administration is typical for these off-label regions.

How it's administered

Botox is delivered by intradermal injection at the treatment site. For underarm use, the affected area is mapped (typically with a Minor's iodine-starch test) and divided into a grid; small doses are injected at each grid point. Total dose varies by region and severity. Underarm doses are typically 50-100 units per side. Hand and foot injections require more sites and may need nerve block or other pain management.

Onset and duration

Effect begins within several days of injection and reaches peak within 2-4 weeks. Duration is typically 4-7 months for underarm use; hand and foot effect duration may be shorter. Repeat treatment is needed as the effect wears off, with cycle length individualized to the patient's response pattern.

Side effects and considerations

Application-site bruising and tenderness are common. Compensatory sweating elsewhere on the body (a concern with surgical sympathectomy) is generally NOT seen with limited to certain areas Botox administration because the whole-body effect is minimal. Transient muscle weakness adjacent to the injection site is uncommon but is the reason hand Botox in particular is performed by clinicians with specific training. Generalized weakness from spread to distal sites is rare but is a documented risk with any Botox use.

Practical considerations

• • Next step: intradermal injection
• • Frequency: every 4-7 months (underarm); shorter cycle for hand/foot in some patients
• • Prescription + clinician administration required
• • FDA indication: severe primary excessive underarm sweating in adults
• • Off-label: hand, foot, face and scalp

Side effects and reasons this may not be safe for you

• • Injection-site bruising and tenderness
• • Transient adjacent muscle weakness (uncommon)
• • Rare allergic reactions
• • Theoretical risk of toxin spread (rare with limited to certain areas use)
• • No compensatory sweating (unlike ETS surgery)

Compare this option

• Compare: botox vs miradry →
• Compare: botox vs brella →

Governed citations

Numbers and approved uses on this page link back to their sources governed in anna-pipeline. Each entry below is a packet bound to this treatment.

Frequently asked

Does Botox for excessive sweating hurt?

Underarm injections are typically well-tolerated with topical anesthetic; many patients describe pinprick sensations rather than significant pain. Hand and foot injections involve thicker, more sensitive skin and more injection sites; nerve block or other pain management is commonly used. The procedure is brief — 15-30 minutes for underarm administration.

How is Botox different from miraDry or Brella?

Botox provides 4-7 months of sweat reduction per treatment cycle and is repeated. miraDry and Brella aim for longer-lasting reduction by physically targeting sweat glands (microwave thermolysis or alkali thermolysis respectively). The choice involves treatment cadence (repeated injections vs fewer sessions), invasiveness, durability, and cost-per-year considerations. The /compare/botox-vs-miradry and /compare/botox-vs-brella pages walk through the tradeoffs.

Can I get Botox for my hands?

Yes — hand Botox is used off-label and is well-established in specialist practice. Treatment is more involved than underarm Botox because of injection-site count, sensitivity, and the need for adequate anesthesia. Effect duration may be slightly shorter than underarm use.

Reading paths

• Check your severity with the HDSS calculator →
• Body regions →
• How claims are governed →

When this treatment is usually considered